Exploring the medicinal potential of Dark Chemical Matters (DCM) to design promising inhibitors for PLpro of SARS-CoV-2 using molecular screening and simulation approaches

The growing concerns and cases of COVID-19 with the appearance of novel variants i.e., BA.2.75. BA.5 and XBB have prompted demand for more effective treatment options that could overcome the risk of immune evasion. For this purpose, discovering novel small molecules to inhibit druggable proteins suc...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Abbas, Liaqat, Ayesha, Masood, Adan, Ali, Syed Shujait, Ali, Liaqat, Alshammari, Abdulrahman, Alasmari, Abdullah F., Mohammad, Anwar, Waheed, Yasir, Wei, Dong-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504533/
https://www.ncbi.nlm.nih.gov/pubmed/37719892
http://dx.doi.org/10.1016/j.jsps.2023.101775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504533/
https://www.ncbi.nlm.nih.gov/pubmed/37719892
http://dx.doi.org/10.1016/j.jsps.2023.101775

Ejemplares similares